⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VBIO News
Valion Bio, Inc. Common Stock
Form 8-K
sec.gov
VBIO
3 Biotech Stocks Throwing Their Weight Around, and Another that Wants to Help You Lose Yours
globenewswire.com
NTHI
CNTB
VBIO
LLY
Valion Bio and Shear Kershman Laboratories Successfully Formulate Oral Mucosal Entolimod; Valion Sees Potential for Multi-Fold Expansion of Long-Term Opportunity
accessnewswire.com
VBIO
Form 8-K
sec.gov
VBIO
Valion Appoints Life Sciences Veteran Dean Zikria as Interim CEO and Announces Board Leadership Transitions
accessnewswire.com
VBIO
Valion Bio Regains Compliance with NASDAQ Minimum Bid Price Listing Rule
accessnewswire.com
VBIO
Sjögren's Syndrome Market to Witness Sustained Growth During the Forecast Period (2026-2036) Due to the Development of Targeted Immunotherapies, FcRn Inhibitors, TYK2 Inhibitors, and Cell Therapies | DelveInsight
prnewswire.com
VBIO
AMGN
JNJ
BMY
IMVT
Valion Bio Announces Changes to Management and Board of Directors
accessnewswire.com
VBIO
Form 8-K
sec.gov
VBIO
ALLR
Form 8-K
sec.gov
VBIO